Analysed INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS) News Sources
Innovent Announces First Patient Dosed in Pivotal Registrational Study of IBI363/TAK-928 (PD-1/IL-2α-biased Bispecific Fusion Protein) in Combination with Bevacizumab in Late-Line Advanced Colorectal Cancer in China
06-08-2026
yahoo.com
Innovent Biologics and Daiichi Sankyo Enter Exclusive Agreement for VANFLYTA® Commercialization in China
10-08-2026
yahoo.com
Innovent and Daiichi Sankyo sign deal for Vanflyta in China
10-08-2026
pharmaceutical-technology.com
Spero Therapeutics Announces Second Quarter 2026 Operating Results and Provides Business Update
12-08-2026
yahoo.com
Market Chatter: Novo Nordisk Reports China Regulators Accept Weight-Loss Drug Application
27-08-2026
yahoo.com
2026 Complement Inhibitors Market Analysis Report (2nd Edition) Featuring Amgen, CSL Behring, Innovent Biologics, Novartis, Regeneron, Roche, Sanofi, Takeda, UCB
02-09-2026
yahoo.com
What is the current price of INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS)?
The current price of INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS) is $12.338.
INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS) since the previous trading day is $0.578.
INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS) since the previous trading day is 4.915%.
What is the most recent average sentiment score for INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS)?
The most recent average sentiment score for INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS) is 67 out of 100.
What is the most recent average sentiment for INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS)?
The most recent sentiment for INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS) is .
SEC-8K** Filing Available For INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.